宣泰医药(688247.SH)拟推2025年限制性股票激励计划

Core Viewpoint - XuanTai Pharmaceutical (688247.SH) has announced a draft for its 2025 restricted stock incentive plan, aiming to grant up to 6.23 million shares, which represents approximately 1.37% of the company's total share capital at the time of the announcement [1] Summary by Categories Incentive Plan Details - The plan includes an initial grant of no more than 4.988 million shares [1] - The initial grant will be allocated to no more than 64 individuals [1] - The grant price is set at 5.71 yuan per share [1]